VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 ?g/mL)
Aug 2025
90d
VITEK COMPACT PRO
Mar 2025
451d
VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 ?g/mL)
Jun 2024
265d
VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 ?g/mL)
Jun 2024
260d
VIDAS TBI (GFAP, UCH-L1)
May 2024
90d
VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 ?g/mL)
Mar 2024
84d
VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 ?g/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 ?g/mL), VITEK 2 Streptococcus Penicillin
Oct 2023
90d
VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 ?g/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 ?g/mL), VITEK 2 AST-GP Daptomycin
Jul 2023
98d
VITEK 2 AST-Gram Negative Levofloxacin (/=8 ug/mL)
Jun 2023
325d
VITEK? 2 AST-Gram Negative Plazomicin (=0.5 - =16 ?g/mL); VITEK? 2 AST-GN Plazomicin (=0.5 - =16 ?g/mL); VITEK? 2 AST-GN Plazomicin
Feb 2023
90d
VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL)
Feb 2023
210d
VITEK? 2 Streptococcus Tetracycline (<=0.25 - >=16 ?g/mL)
Feb 2023
77d
VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 ?g/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 ?g/mL), VITEK 2 AST-GP Moxifloxacin
Jan 2023
315d
VITEK 2 AST-Gram Positive Cefoxitin Screen
Oct 2022
209d
VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 ?g/mL)
Aug 2022
385d
VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 ?g/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 ?g/mL), VITEK 2 AST-YS Caspofungin
Jul 2022
210d
VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 ?g/mL)
Jun 2022
169d
VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 ?g/mL)
Apr 2022
113d
VITEK MS PRIME
Mar 2022
221d
VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 ?g/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 ?g/mL), VITEK 2 AST-YS Fluconazole
Feb 2022
148d
VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL)
Oct 2021
268d
VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL)
Sep 2021
389d
VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 ?g/mL)
Aug 2021
95d
VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 ?g/mL)
Jul 2021
385d
VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML)
Jun 2021
59d